目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Segment
2.2.2. End-use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights

Chapter 3. Global Poly-L-lactic Acid (PLLA) Filler Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for minimally invasive cosmetic procedures
3.2.1.2. Aging population and rising focus on anti-aging solutions
3.2.1.3. Technological advancements and product innovations
3.2.1.4. Growing awareness and acceptance of cosmetic enhancements
3.2.2. Market restraint analysis
3.2.2.1. Stringent Regulatory Policies
3.3. Poly-L-lactic Acid (PLLA) Filler Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Poly-L-lactic Acid (PLLA) Filler Market: Application Estimates & Trend Analysis
4.1. Poly-L-lactic Acid (PLLA) Filler Market: Application Dashboard
4.2. Poly-L-lactic Acid (PLLA) Filler Market: Application Movement Analysis
4.3. Poly-L-lactic Acid (PLLA) Filler Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Face
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Neck
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Abdomen
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Knees
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.8. Thighs
4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Poly-L-lactic Acid (PLLA) Filler Market: End-use Estimates & Trend Analysis
5.1. Poly-L-lactic Acid (PLLA) Filler Market: End-use Dashboard
5.2. Poly-L-lactic Acid (PLLA) Filler Market: End-use Movement Analysis
5.3. Poly-L-lactic Acid (PLLA) Filler Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Medspas
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Cosmetic Surgery Centers/Dermatology Clinics
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Poly-L-lactic Acid (PLLA) Filler Market: Regional Estimates & Trend Analysis by Country, Application, and End-use
6.1. Global Poly-L-lactic Acid (PLLA) Filler Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. France market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. China market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. India market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.1.1. Key company market share analysis, 2024
7.1.2. Galderma
7.1.2.1. Company overview
7.1.2.2. Financial performance
7.1.2.3. End-use benchmarking
7.1.2.4. Strategic initiatives
7.1.3. GANA RND
7.1.3.1. Company overview
7.1.3.2. Financial performance
7.1.3.3. End-use benchmarking
7.1.3.4. Strategic initiatives
7.1.4. Sinclair Pharma
7.1.4.1. Company overview
7.1.4.2. Financial performance
7.1.4.3. End-use benchmarking
7.1.4.4. Strategic initiatives
7.1.5. PRP Science
7.1.5.1. Company overview
7.1.5.2. Financial performance
7.1.5.3. End-use benchmarking
7.1.5.4. Strategic initiatives
7.1.6. Laboratories Hyamed SA
7.1.6.1. Company overview
7.1.6.2. Financial performance
7.1.6.3. End-use benchmarking
7.1.6.4. Strategic initiatives
7.1.7. Dermax Co., Ltd
7.1.7.1. Company overview
7.1.7.2. Financial performance
7.1.7.3. End-use benchmarking
7.1.7.4. Strategic initiatives
7.1.8. Rimless Industry Co., Ltd.
7.1.8.1. Company overview
7.1.8.2. Financial performance
7.1.8.3. End-use benchmarking
7.1.8.4. Strategic initiatives
7.1.9. Hangzhou Singclean Medical Products Co.,Ltd
7.1.9.1. Company overview
7.1.9.2. Financial performance
7.1.9.3. End-use benchmarking
7.1.9.4. Strategic initiatives
7.1.10. LINKUS GLOBAL Co., Ltd.
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. End-use benchmarking
7.1.10.4. Strategic initiatives

List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation

List of Figures
Fig 1. Poly-l-lactic acid (PLLA) filler market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value chain-based sizing & forecasting
Fig 7. QFD modelling for market share assessment
Fig 8. Poly-l-lactic acid (PLLA) filler market revenues, 2024, (USD Millions)
Fig 9. Market driver relevance analysis (Current & future impact)
Fig 10. Market restraint relevance analysis (Current & future impact)
Fig 11. Porter’s five forces analysis
Fig 12. PESTLE analysis
Fig 13. Poly-l-lactic acid (PLLA) filler market Application outlook:
Fig 14. Poly-l-lactic acid (PLLA) filler market: Application movement analysis
Fig 15. Segment dashboard
Fig 16. Global face market, 2018-2030 (USD Million)
Fig 17. Global neck market, 2018-2030 (USD Million)
Fig 18. Global abdomen market, 2018-2030 (USD Million)
Fig 19. Global knees market, 2018-2030 (USD Million)
Fig 20. Global thighs market, 2018-2030 (USD Million)
Fig 21. Global others market, 2018-2030 (USD Million)
Fig 22. Poly-l-lactic acid (PLLA) filler market end-use outlook:
Fig 23. Poly-l-lactic acid (PLLA) filler market: end-use movement analysis
Fig 24. Global medspas market, 2018-2030 (USD Million)
Fig 25. Global Cosmetic Surgery Centers/Dermatology Clinics market, 2018-2030 (USD Million)
Fig 26. Regional market place: Key takeaways
Fig 27. North America poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 28. U.S. poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 29. Canada poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 30. Mexico poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 31. Europe poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 32. Germany poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 33. UK poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 34. France poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 35. Italy poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 36. Spain poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 37. Asia Pacific poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 38. Japan poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 39. China poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 40. India poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 41. Australia poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 42. Latin America poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 43. Brazil poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 44. MEA poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 45. South Africa poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 46. Saudi Arabia poly-l-lactic acid (PLLA) filler market, 2018-2030 (USD Million)
Fig 47. Market Participant Categorization
Fig 48. Strategy mapping